Cell & Gene Therapy Investor Forum

Investing in ATMP: From Breakthroughs to Scalable Therapies

– Organized by CCRM Nordic & ATMP Flemmingsberg 

ATMP is at an inflection point, where significant scientific progress is now meeting increasing expectations on scalability, cost, and commercial viability. This creates a growing need for stronger alignment across the ecosystem – bringing together developers, investors, technology providers, and enabling organizations.

This joint event, hosted by CCRM Nordic and ATMP Flemmingsberg, is a dedicated investor-focused session designed to connect capital with the ATMP ecosystem. It offers a unique opportunity for investors to gain a structured understanding of the field, explore the latest developments, and engage directly with companies and experts shaping the future of cell and gene therapy.

Who should attend?

• Investors who are either new or experienced in ATMP
• Developers of ATMPs and supportive technology

Why attend?

• Get experts view of where the ATMP field is today – and where it is heading
• Understand what has changed in recent years and what still remains challenging
• Learn what makes an ATMP company investable
• Explore technologies enabling scalability
• Connect directly with leading companies and investors in the space

Event details

Date: Monday, November 30th 2026
Location: Auditorium at Campus Flemingsberg, Stockholm
Time: 13:00 – 18:00

Agenda

13:00 – 13:30: Welcome and introduction

13:30 – 14:15: Keynote, “New developments and key research findings“
An overview of recent scientific, technological and clinical progress in ATMP, including key learnings from past successes and challenges.

14:15 – 14:30: Break

14:30 – 15:00: Presentation, “Breaking the ATMP cost barrier – technologies enabling scalable therapies“
Presentation on manufacturing innovations and technologies that reduce cost of goods and enable commercially viable products. Followed by Q&A.

15:00 – 15:45: Panel “Investing in ATMP – what investors actually look for“
A candid discussion on investment criteria, risks, and opportunities in ATMP, including lessons learned from past failures and what defines an investable company today. Followed by Q&A.

15:45 – 16:00: Break

16:00 – 17:00: Company pitch sessions
Selected ATMP and supportive technology companies present their opportunities to investors.

17:00 – 18:00: Networking and drinks

Registration

Register your interest here.

Registration deadline: October 31st

As this is an exclusive event with limited capacity, all registrations are subject to review. Priority will be given to investors, ATMP developers, and developers of enabling technologies. We therefore reserve the right to decline registrations that do not align with the intended audience for the event.

About CCRM Nordic
CCRM Nordic is a leading organization dedicated to advancing research, development, and commercialization of advanced therapy medicinal products (ATMPs). With a focus on innovation and collaboration, CCRM Nordic strives to accelerate the translation of scientific discoveries into tangible therapies that address unmet medical needs. Learn more about CCRM Nordic: ccrmnordic.se

Event Contact:

Stephanie Mattsson, Director Venture Development, CCRM Nordic

stephanie.mattsson@ccrmnordic.se

+46 730 259089